Skip to content

Finance of America Companies FOA Sale of stock, price per share (in dollars per share)

Sale of stock, price per share (in dollars per share) at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$0.01
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$60.00
electroCore, Inc. logo
electroCore, Inc.ECOR
$6.62
SKYX Platforms Corp. logo
SKYX Platforms Corp.SKYX
$1.20
CBAK Energy Technology, Inc. logo
CBAK Energy Technology, Inc.CBAT
$5.18
New America Acquisition I
 logo
New America Acquisition I NWAX
$10.00

Other financials

Income statement

See full
Revenue$120.1M-27.5%
Net income$17.5M-42.0%
EPS (diluted)$0.88-63.8%

Balance sheet

See full
Cash & equivalents$376.6M+49.5%
Total debt$899.3M-10.9%
Total equity$438.1M+10.9%
Total assets$31.3B+5.5%

Cash flow

See full
Operating cash flow-$130.9M-42.1%
CapEx$461.0K-76.0%
Free cash flow-$132.7M-160%

Valuation

See full
Market cap$244.7M-4.9%
Enterprise value$767.43M-30.1%
P/E3.4×
P/S0.5×

Profitability

See full
Operating margin-0.5%
Net margin-858.3%-1,072pp
FCF margin883.8%+882pp

Returns & leverage

See full
Return on equity-58.5%+115pp
Debt / equity2.1×-0.5×
Current ratio0.1×

Where this comes from

Reported directly by Finance of America Companies in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockPricePerShare.

The official record: Finance of America Companies’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Finance of America Companies's sale of stock, price per share (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Finance of America Companies's sale of stock, price per share (in dollars per share)?
Finance of America Companies (FOA) reported sale of stock, price per share (in dollars per share) of $1,000.00 in Q4 2025.
What does sale of stock, price per share (in dollars per share) mean?
The average or specific price at which the company issued new equity shares to investors during the period. This metric reflects the market's valuation of the company's equity at the time of issuance and the dilution impact on existing shareholders. It is a key indicator of the company's ability to raise capital and the perceived value of its stock by the market.